MedMen Enterprises Inc. MMNFF's fiscal third-quarter results saw increased revenue by 22 percent to $36.6 million across operations in California, Nevada, New York, Arizona and Illinois.
MedMen continued to perform favorably in California with $24.9 million in retail revenue and retail gross margins increasing to 57 percent.
MedMen reported its revenue from pending acquisitions and pre-closing revenue from recently closed acquisitions, pro forma quarterly revenue was approximately $57 million.
MedMen decreased corporate selling, general and administrative expense by 9 percent quarter over quarter with a plan to achieve an overall 20 percent reduction from the previous quarter. The company also announced a $250 million financing commitment from Gotham Green Partners.
MedMen's stock traded around $2.37 per share at time of publication.
Related Links:
Cresco Labs Reports Q1 Sales Of $21.1M, Up 313% Year Over Year
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Top Cannabis Event In New Jersey
Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!